Used in pharmaceutical research as a key intermediate in the synthesis of biologically active compounds, particularly in the development of central nervous system agents. Its structure supports the design of inhibitors targeting specific enzymes or receptors due to the presence of trifluoromethyl and benzyl groups, which enhance metabolic stability and binding affinity. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies to optimize drug candidates. Also utilized in the preparation of pyrrolidine-based analogs for screening in neurodegenerative disease and psychiatric disorder research.